1. Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019. (7th July 2021) Authors: Subramaniam, Saravanan; Ruf, Wolfram; Bosmann, Markus Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alzheimer's disease and cerebrovascular pathology alter inward rectifier potassium (KIR2.1) channels in endothelium of mouse cerebral arteries. (10th February 2022) Authors: Lacalle‐Aurioles, María; Trigiani, Lianne J.; Bourourou, Miled; Lecrux, Clotilde; Hamel, Edith Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CORRECTION. (5th April 2022) Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic‐ and cholestatic‐induced liver injury. (10th February 2022) Authors: Benitez, Raquel; Caro, Marta; Andres‐Leon, Eduardo; O'Valle, Francisco; Delgado, Mario Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Delineating the interactions between the cannabinoid CB2 receptor and its regulatory effectors; β‐arrestins and GPCR kinases. (7th February 2022) Authors: Patel, Monica; Matti, Christoph; Grimsey, Natasha L.; Legler, Daniel F.; Javitch, Jonathan A.; Finlay, David B.; Glass, Michelle Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID‐19. (17th April 2021) Authors: Cinar, Resat; Iyer, Malliga R.; Kunos, George Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Endothelial TRPV4–eNOS coupling as a vital therapy target for treatment of hypertension. (28th January 2022) Authors: Mao, Aiqin; Zhang, Peng; Zhang, Ka; Kan, Hao; He, Dongxu; Han, Xiping; Wang, Zhiwei; Tang, Chunlei; Ma, Xin Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Glucosylsphingosine evokes pruritus via activation of 5‐HT2A receptor and TRPV4 in sensory neurons. (4th February 2022) Authors: Sanjel, Babina; Kim, Bo‐Hyun; Song, Myung‐Hyun; Carstens, Earl; Shim, Won‐Sik Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Issue Information. (5th April 2022) Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence. (12th March 2021) Authors: Pignataro, Giuseppe; Cataldi, Mauro; Taglialatela, Maurizio Other Names: Cirino Giuseppe guestEditor.; Ahluwalia Amrita guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 10(2022) Page Start: 2149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗